First among equals: The cancer cell hierarchy

Leukemia and Lymphoma

Volumn 47, Issue 10, 2006, Pages 2017-2027

  Ichim, Christine V ^a,b   Wells, Richard A ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Cancer stem cells; Cell proliferation; Differentiation; Hierarchy; Leukemia; Self renewal

Indexed keywords

CANCER; CANCER CELL; CANCER STEM CELL; CANCER THERAPY; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; LEUKEMIA; MODELS, BIOLOGICAL; NEOPLASMS; STEM CELLS;

EID: 33750437419     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600733325     Document Type: Review

References (92)

1. Hope, K and Jin, L and Dick, J. (2004) Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity Nat Immunol, 5, pp. 738-743.
2. Al-Hajj, M and Wicha, M and Benito-Hernandez, A and Morrison, S and Clarke, M. (2003) Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci (USA), 100, pp. 3983-3988.
3. Singh, S and Clarke, I and Terasaki, M and Bonn, V and Hawkins, C and Squire, J and Dirks, P. (2003) Identification of a cancer stem cell in human brain tumors Cancer Res, 63, pp. 5821-5828.
4. Bonnet, D and Dick, J. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med, 3, pp. 730-737.
5. Collins, A and Berry, P and Hyde, C and Stower, M and Maitland, N. (2005) Prospective identification of tumorigenic prostate cancer stem cells Cancer Res, 65, pp. 10946-10951.
6. Mendelsohn, M. (1960) The growth fraction: A new concept applied to tumors Science, 132, pp. 1496.
7. Mendelsohn, M. (1962) Chronic infusion of iritiated ihymidine into mice with tumors Science, 135, pp. 213.
8. Mendelsohn, M. (1962) Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse. III. The growth fraction J Natl Cancer Inst, 28, pp. 1015.
9. Wylie, C and Nakane, P and Pierce, G. (1973) Degree of differentiation in nonproliferating cells of mammary carcinoma Differentiation, 1, pp. 11-20.
10. Steel, G and Lamerton, L. (1966) The growth rate of human tumors Br J Cancer, 20, pp. 74-86.
11. Steel, G. (1967) Cell loss as a factor in the growth rate of human tumors Eur J Cancer, 3, pp. 381-387.
12. Clarkson, B.(1970) Consideration of the cell cycle in chemotherapy of acute leukemia. In Current concepts in the management of lymphoma and leukemia. (pp. 88-118). Berlin: Springer-Verlag.
13. Clarkson, B. (1969) Review of recent studies of cellular proliferation in acute leukemia Natl Cancer Inst Monogr, 30, pp. 81-120.
14. Frei, E and Freireich, E.(1965) Progress and perspectives in the chemotherapy of acute leukemia. In Advances in chemotherapy. (pp. 269). New York: Academic Press.
15. Clarkson, B and Fried, J and Strife, A and Sakai, Y and Ota, K and Okita, T. (1970) Studies of cellular proliferation in human leukemia. 3. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days Cancer, 25, pp. 1237-1260.
16. Burchenal, J. (1968) Long-term survivors in acute leukemia and Burkitt's tumor Cancer, 21, pp. 595-599.
17. Bush, R and Hill, R. (1975) Biologic discussions augmenting radiation effects and model systems Laryngoscope, 85, pp. 1119-1133.
18. Moore, J and Hendry, J and Hunter, R. (1983) Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells Radiother Oncol, 1, pp. 143-157.
19. Salmon, S and Hamburger, A and Soehnlen, B and Durie, B and Alberts, D and Moon, T. (1978) Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs N Engl J Med, 298, pp. 1321-1327.
20. Lapidot, T and Sirard, C and Vormoor, J and Murdoch, B and Hoang, T and Caceres-Cortes, J and (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature, 367, pp. 645-648.
21. Singh, S and Hawkins, C and Clarke, I and Squire, J and Bayani, J and Hide, T and (2004) Identification of human brain tumour initiating cells Nature, 432, pp. 396-401.
22. Southam, C and Brunschwig, A and Dizon, Q.(1962) Autologous and homologous transplantation of human cancer. In Biological interactions in normal and neoplastic growth. (pp. 723-738). Boston MA: Little, Brown and Company.
23. Southam, C and Brunschwig, A. (1961) Quantitative studies of autotransplantation of human cancer - preliminary report Cancer, 14, pp. 971.
24. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and Sultan, C. (1976) Proposals for the classification of the acute leukaemias French-American-British (FAB) co-operative group. Br J Haematol, 33, pp. 451-458.
25. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia A report of the French-American-British Cooperative Group. Ann Intern Med, 103, pp. 620-625.
26. Freeman, J. (1960) The ultrastructure and genesis of Auer bodies Blood, 15, pp. 449-465.
27. Stass, S and Lanham, G and Butler, D and Williams, D and Peiper, S and Kalwinsky, D and Dahl, G. (1984) Auer rods in mature granulocytes: A unique morphologic feature of acute myelogenous leukemia with maturation Am J Clin Pathol, 81, pp. 662-665.
28. Davies, A. (1968) Auer bodies in mature neutrophils Jama, 203, pp. 895.
29. Bainton, D and Friedlander, L and Shohet, S. (1977) Abnormalities in granule formation in acute myelogenous leukemia Blood, 49, pp. 693-704.
30. Fialkow, P and Singer, J and Adamson, J and Vaidya, K and Dow, L and Ochs, J and Moohr, J. (1981) Acute nonlymphocytic leukemia: heterogeneity of stem cell origin Blood, 57, pp. 1068-1073.
31. Fearon, E and Burke, P and Schiffer, C and Zehnbauer, B and Vogelstein, B. (1986) Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia N Engl J Med, 315, pp. 15-24.
32. Jacobson, R and Temple, M and Singer, J and Raskind, W and Powell, J and Fialkow, P. (1984) A clonal complete remission in a patient with acute nonlymphocytic leukemia originating in a multipotent stem cell N Engl J Med, 310, pp. 1513-1517.
33. Fialkow, P and Singer, J and Raskind, W and Adamson, J and Jacobson, R and Bernstein, I and (1987) Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia N Engl J Med, 317, pp. 468-473.
34. Lajtha, L. (1981) Which are the leukaemic cells Blood Cells, 7, pp. 45-62.
35. Foulds, L. (1954) The experimental study of tumor progression: A review Cancer Res, 14, pp. 327-339.
36. van Duuren, B and Sivak, A and Katz, C and Seidman, I and Melchionne, S. (1975) The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin Cancer Res, 35, pp. 502-505.
37. Horton, S and Grier, D and McGonigle, G and Thompson, A and Morrow, M and de Silva, I and (2005) Continuous MLL-ENL expression is necessary to establish a 'Hox Code' and maintain immortalization of hematopoietic progenitor cells Cancer Res, 65, pp. 9245-9252.
38. Cozzio, A and Passegue, E and Ayton, P and Karsunky, H and Cleary, M and Weissman, I. (2003) Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors Genes Dev, 17, pp. 3029-3035.
39. Huntly, B and Shigematsu, H and Deguchi, K and Lee, B and Mizuno, S and Duclos, N and (2004) MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors Cancer Cell, 6, pp. 587-596.
40. Jamieson, C and Ailles, L and Dylla, S and Muijtjens, M and Jones, C and Zehnder, J and (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML N Engl J Med, 351, pp. 657-667.
41. Miyamoto, T and Nagafuji, K and Akashi, K and Harada, M and Kyo, T and Akashi, T and (1996) Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia Blood, 87, pp. 4789-4796.
42. Biernaux, C and Loos, M and Sels, A and Huez, G and Stryckmans, P. (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals Blood, 86, pp. 3118-3122.
43. Bose, S and Deininger, M and Gora-Tybor, J and Goldman, J and Melo, J. (1998) The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease Blood, 92, pp. 3362-3367.
44. Limpens, J and de Jong, D and van Krieken, J and Price, C and Young, B and van Ommen, G and Kluin, P. (1991) Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia Oncogene, 6, pp. 2271-2276.
45. Trumper, L and Pfreundschuh, M and Bonin, F and Daus, H. (1998) Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals Br J Haematol, 103, pp. 1138-1144.
46. Maes, B and Vanhentenrijk, V and Wlodarska, I and Cools, J and Peeters, B and Marynen, P and de Wolf-Peeters, C. (2001) The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells Am J Pathol, 158, pp. 2185-2193.
47. Marcucci, G and Strout, M and Bloomfield, C and Caligiuri, M. (1998) Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: Distinct origin of normal versus leukemic ALL1 fusion transcripts Cancer Res, 58, pp. 790-793.
48. Disperati, P and Ichim, C and Tkachuk, D and Chun, K and Schuh, A and Wells, R. (2006) Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biology Leuk Res, 30, pp. 233-239.
49. Blackstock, A and Garson, O. (1974) Direct evidence for involvement of erythroid cells in acute myeloblastic leukaemia Lancet, 2, pp. 1178-1179.
50. Ferraris, A and Raskind, W and Bjornson, B and Jacobson, R and Singer, J and Fialkow, P. (1985) Heterogeneity of B cell involvement in acute nonlymphocytic leukemia Blood, 66, pp. 342-344.
51. Jensen, M and Killmann, S. (1971) Additional evidence for chromosome abnormalities in the erythroid precursors in acute leukaemia Acta Med Scand, 189, pp. 97-100.
52. Keinanen, M and Griffin, J and Bloomfield, C and Machnicki, J and de la Chapelle, A. (1988) Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia N Engl J Med, 318, pp. 1153-1158.
53. Suciu, S and Zeller, W and Weh, H and Hossfeld, D. (1993) Immunophenotype of mitotic cells with clonal chromosome abnormalities demonstrating multilineage involvement in acute myeloid leukemia Cancer Genet Cytogenet, 70, pp. 1-5.
54. Blair, A and Hogge, D and Sutherland, H. (1998) Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR Blood, 92, pp. 4325-4335.
55. Curtis, J and Messner, H and Hasselback, R and Elhakim, T and McCulloch, E. (1984) Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia J Clin Oncol, 2, pp. 253-259.
56. Sutherland, H and Blair, A and Vercauteren, S and Zapf, R. (2001) Detection and clinical significance of human acute myeloid leukaemia progenitors capable of long-term proliferation in vitro Br J Haematol, 114, pp. 296-306.
57. Hill, R and Milas, L. (1989) The proportion of stem cells in murine tumors Int J Radiat Oncol Biol Phys, 16, pp. 513-518.
58. Sawyers, C and Hochhaus, A and Feldman, E and Goldman, J and Miller, C and Ottmann, O and (2002) Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: Results of a phase II study Blood, 99, pp. 3530-3539.
59. Talpaz, M and Silver, R and Druker, B and Goldman, J and Gambacorti-Passerini, C and Guilhot, F and (2002) Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: Results of a phase 2 study Blood, 99, pp. 1928-1937.
60. Bhatia, R and Holtz, M and Niu, N and Gray, R and Snyder, D and Sawyers, C and (2003) Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment Blood, 101, pp. 4701-4707.
61. Chu, S and Xu, H and Shah, N and Snyder, D and Forman, S and Sawyers, C and Bhatia, R. (2005) Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment Blood, 105, pp. 2093-2098.
62. Michor, F and Hughes, T and Iwasa, Y and Branford, S and Shah, N and Sawyers, C and Nowak, M. (2005) Dynamics of chronic myeloid leukaemia Nature, 435, pp. 1267-1270.
63. Friend, C and Scher, W and Holland, J and Sato, T. (1971) Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: Stimulation of erythroid differentiation by dimethyl sulfoxide Proc Natl Acad Sci (USA), 68, pp. 378-382.
64. Andreeff, M and Stone, R and Michaeli, J and Young, C and Tong, W and Sogoloff, H and (1992) Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: A phase II clinical trial with a differentiation-inducing agent Blood, 80, pp. 2604-2609.
65. Lichtman, M. (2001) Differentiation versus maturation of neoplastic hematopoietic cells: An important distinction Blood Cells Mol Dis, 27, pp. 649-652.
66. Siminovitch, L and McCulloch, E and Till, J. (1963) The distribution of colony-forming cells among spleen colonies J Cell Comp Physiol, 62, pp. 327-336.
67. Till, J and McCulloch, E and Siminovitch, L. (1964) A stochastic model of stem cell proliferation based on the growth of spleen colony-forming cells Proc Natl Acad Sci (USA), 51, pp. 29-36.
68. Schofield, R. (1978) The relationship between the spleen colony-forming cell and the haemopoietic stem cell Blood Cells, 4, pp. 7-25.
69. Lord, B. (1990) The architecture of bone marrow cell populations Int J Cell Cloning, 8, pp. 317-331.
70. Calvi, L and Adams, G and Weibrecht, K and Weber, J and Olson, D and Knight, M and (2003) Osteoblastic cells regulate the haematopoietic stem cell niche Nature, 425, pp. 841-846.
71. Lord, B and Hendry, J. (1972) The distribution of haemopoietic colony-forming units in the mouse femur, and its modification by x rays Br J Radiol, 45, pp. 110-115.
72. Lord, B and Testa, N and Hendry, J. (1975) The relative spatial distributions of CFUs and CFUc in the normal mouse femur Blood, 46, pp. 65-72.
73. Arai, F and Hirao, A and Ohmura, M and Sato, H and Matsuoka, S and Takubo, K and (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche Cell, 118, pp. 149-161.
74. Zhang, J and Niu, C and Ye, L and Huang, H and He, X and Tong, W and (2003) Identification of the haematopoietic stem cell niche and control of the niche size Nature, 425, pp. 836-841.
75. Reya, T and Duncan, A and Ailles, L and Domen, J and Scherer, D and Willert, K and (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells Nature, 423, pp. 409-414.
76. Jian, H and Shen, X and Liu, I and Semenov, M and He, X and Wang, X. (2006) Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells Genes Dev, 20, pp. 666-674.
77. Alexson, T and Hitoshi, S and Coles, B and Bernstein, A and van der Kooy, D. (2006) Notch signaling is required to maintain all neural stem cell populations - irrespective of spatial or temporal niche Dev Neurosci, 28, pp. 34-48.
78. Duncan, A and Rattis, F and DiMascio, L and Congdon, K and Pazianos, G and Zhao, C and (2005) Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance Nat Immunol, 6, pp. 314-322.
79. Lessard, J and Sauvageau, G. (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells Nature, 423, pp. 255-260.
80. Nakauchi, H and Oguro, H and Negishi, M and Iwama, A. (2005) Polycomb gene product Bmi-1 regulates stem cell self-renewal Ernst Schering Res Found Workshop, pp. 85-100.
81. Iwama, A and Oguro, H and Negishi, M and Kato, Y and Morita, Y and Tsukui, H and (2004) Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1 Immunity, 21, pp. 843-851.
82. Beslu, N and Krosl, J and Laurin, M and Mayotte, N and Humphries, K and Sauvageau, G. (2004) Molecular interactions involved in HOXB4-induced activation of HSC self-renewal Blood, 104, pp. 2307-2314.
83. Ema, H and Sudo, K and Seita, J and Matsubara, A and Morita, Y and Osawa, M and (2005) Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice Dev Cell, 8, pp. 907-914.
84. Zeng, H and Yucel, R and Kosan, C and Klein-Hitpass, L and Moroy, T. (2004) Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells Embo J, 3, pp. 4116-4125.
85. Hock, H and Hamblen, M and Rooke, H and Schindler, J and Saleque, S and Fujiwara, Y and Orkin, S. (2004) Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells Nature, 431, pp. 1002-1007.
86. Kato, Y and Iwama, A and Tadokoro, Y and Shimoda, K and Minoguchi, M and Akira, S and (2005) Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis J Exp Med, 202, pp. 169-179.
87. Burns, C and Traver, D and Mayhall, E and Shepard, J and Zon, L. (2005) Hematopoietic stem cell fate is established by the Notch-Runx pathway Genes Dev, 19, pp. 2331-2342.
88. Zhu, J and Zhang, Y and Joe, G and Pompetti, R and Emerson, S. (2005) NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal Proc Natl Acad Sci (USA), 102, pp. 11728-11733.
89. Iwasaki, H and Somoza, C and Shigematsu, H and Duprez, E and Iwasaki-Arai, J and Mizuno, S and (2005) Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation Blood, 106, pp. 1590-1600.
90. Blair, A and Sutherland, H. (2000) Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117) Exp Hematol, 28, pp. 660-671.
91. Blair, A and Hogge, D and Ailles, L and Lansdorp, P and Sutherland, H. (1997) Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo Blood, 89, pp. 3104-3112.
92. Jordan, C and Upchurch, D and Szilvassy, S and Guzman, M and Howard, D and Pettigrew, A and (2000) The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells Leukemia, 14, pp. 1777-1784.